At Life Technologies, we work behind the scenes, arming scientists and researchers with the technologies they need to advance scientific discovery. As the life sciences, and in particular, genomics, have evolved, we have moved closer to the process of discovery, sometimes working side by side with researchers at the bench, striving to stay ahead of them to anticipate what they might need next. We are poised to move as a company once again, this time closer to the clinical setting, as we become part of the medical diagnostic community.

Last year was a pivotal one for our company, as we named our first Chief Medical Officer and acquired a significant business with an important technology, the Ion Torrent™ Personal Genome Machine™. Both are critical in our commitment to developing the tools that advance how genomic research today can be translated into effective clinical treatments in the future. The pace of innovation is rapid, and the need for solutions that affect human health requires ever greater velocity.

We are committed to taking the steps necessary, from the introduction of new products and educational initiatives to strategic investments and collaborations, to enable the translation of sequencing solutions from the research lab to the clinic. The advent of personalized medicine has begun.

Being a catalyst for the evolution of personalized medicine is just one way that Life Technologies is contributing to solutions that improve the human condition. Our systems, products and services enable us to help solve many of society’s most critical issues, from the depletion of our natural resources to the proliferation of global disease to the very real concern of climate change.

Behind every great discovery, behind every technological advance, behind every new product, are the people of Life Technologies. Inquisitive and driven, passionate and insightful, pioneering and innovative, they are committed to our shared responsibility as global citizens. Bridging the gap between the life sciences of today and their potential to help us create a better tomorrow requires massive collaboration, new levels of partnership and influence that we are just beginning to appreciate. As we look to the future, we do so with the knowledge that our journey is very much a shared one.

We have much to celebrate as a company, as an industry, and I salute the people of Life Technologies who are and will continue to be part of this success.

Gregory T. Lucier

Chairman and Chief Executive Officer